Global Diagnostic Specialty Enzymes Market

Diagnostic Specialty Enzymes Comprehensive Study by Type (Protease, Carbohydrase, Lipase, Polymerase and Nuclease, Others), Application (Food and Beverages, Household Care, Bioenergy, Pharmaceutical and Biotechnology, Feed, Others), Source (Microorganisms, Plants, Animals), Reaction Type (Hydrolase, Oxidoreductase, Transferase, Lyase, Others) Players and Region - Global Market Outlook to 2028

Diagnostic Specialty Enzymes Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 6.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Diagnostic Specialty Enzymes Market Scope
Specialty enzymes play an important role in the process of diagnosis of diseases such as cancer, lysosomal disorders, and cardiovascular diseases. These specialty enzymes that are necessary for the diagnostics have to be of the highest purity and also in small quantity, which further results towards high costs and less adoption of the diagnostic enzymes. With the ongoing demographic shift towards older masses in the developed regions would also support the higher diagnostic specialty enzymes demand. The research and biotechnology will also continue to gain advantage from the vigorous investment in the biotechnology sector which are seen at the corporate and national levels. The growing economies and rising disposable incomes have also boosted the demand for much-improved health care. The usage of these specialty enzymes would continue to grow at a much faster rate than the industrial enzymes. Also, the diagnostic, research and biotechnology enzymes would achieve the firmest gains as advances in diagnostic tests. This would further lead to an expansion in the testing for various agricultural, medical applications, food, and also the large pharmaceutical companies that have continued to boost the research and development spending on the biologics so as to expand the new drug channels.

AttributesDetails
Study Period2018-2028
Base Year2022
Largest MarketNorth America
UnitValue (USD Million)
Key Companies ProfiledBASF (Germany), Novozymes (Denmark), Roche Holding (Switzerland), DuPont (United States), Roche Holding AG (Switzerland), Codexis Inc. (United States), Dyadic International (United States), Amano Enzymes (Japan), Sanofi (France), Biocatalysts (United Kingdom), Life Technologies (United States), Advance Enzyme Technologies Ltd (India), Affymetrix, Inc. (United States), Enzyme Supplies (United Kingdom), BBI Solutions (United Kingdom), Specialty Enzymes & Probiotics (United States), Amicogen (South Korea), Antozyme Biotech (India) and Enzyme Development Corporation (United States)
CAGR6.9%


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that European Players will contribute to the maximum growth of Global Diagnostic Specialty Enzymes market throughout the predicted period.

BASF (Germany), Novozymes (Denmark), Roche Holding (Switzerland), DuPont (United States), Roche Holding AG (Switzerland), Codexis Inc. (United States), Dyadic International (United States), Amano Enzymes (Japan), Sanofi (France), Biocatalysts (United Kingdom), Life Technologies (United States), Advance Enzyme Technologies Ltd (India), Affymetrix, Inc. (United States), Enzyme Supplies (United Kingdom), BBI Solutions (United Kingdom), Specialty Enzymes & Probiotics (United States), Amicogen (South Korea), Antozyme Biotech (India) and Enzyme Development Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Nagase & Co. Ltd. (Japan), Sekisui Diagnostics (United States), Merck (Germany), Biovet (Bulgaria) and Biotec Pharmacon.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Diagnostic Specialty Enzymes market by Type , by Application (Food and Beverages, Household Care, Bioenergy, Pharmaceutical and Biotechnology, Feed and Others) and Region with country level break-up.

On the basis of geography, the market of Diagnostic Specialty Enzymes has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In May 2019, Codexis, Inc. a leading protein engineering company, had acquired Novartis. The acquisition expand the portfolio of company.
In December 2022, Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity,has launched of Ginkgo Enzyme Services. Ginkgo Enzyme Services is powered by ultra high throughput screening and machine learning-guided protein design, as well as optimized proprietary bacterial and fungal host strains., In February 2019, the subsidiary of Biotec Pharmacon called ArcticZymes launched its first ligase enzyme called the T4 DNA ligase, the most widely used enzyme in the ligase family. and DuPont Nutrition & Biosciences launched its industry-leading OPTIMISE portfolio. This portfolio contains bio-based enzymes, which will be used for the cleaning of medical instruments.


Influencing Trend:
Increasing Utilization of Diagnostic Specialty Enzymes in Biofuels and Pulp & Paper Industry and Rising Trend of Enzymes in Engineering

Market Growth Drivers:
Rising Number for Patient Suffering From Chronic Diseases, Rising in Prevalence of Digestive Disorders, Increasing Demand for Biofuels and Rising Demand for Effective Diagnostic Specialty Enzymes Based Pharmaceuticals

Challenges:
Safety and Handling Issues Associated to Specialty Enzymes

Restraints:
Problems Associated with the Chemical and Physical Properties of Specialty Enzymes

Opportunities:
Increasing Utilization of Specialty Enzymes in Protein Engineering and Changing Life Style and Rising Health Awareness across Globe

Key Target Audience
Providers of Diagnostic Specialty Enzymes, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Protease
  • Carbohydrase
  • Lipase
  • Polymerase and Nuclease
  • Others
By Application
  • Food and Beverages
  • Household Care
  • Bioenergy
  • Pharmaceutical and Biotechnology
  • Feed
  • Others
By Source
  • Microorganisms
  • Plants
  • Animals

By Reaction Type
  • Hydrolase
  • Oxidoreductase
  • Transferase
  • Lyase
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number for Patient Suffering From Chronic Diseases
      • 3.2.2. Rising in Prevalence of Digestive Disorders
      • 3.2.3. Increasing Demand for Biofuels
      • 3.2.4. Rising Demand for Effective Diagnostic Specialty Enzymes Based Pharmaceuticals
    • 3.3. Market Challenges
      • 3.3.1. Safety and Handling Issues Associated to Specialty Enzymes
    • 3.4. Market Trends
      • 3.4.1. Increasing Utilization of Diagnostic Specialty Enzymes in Biofuels and Pulp & Paper Industry
      • 3.4.2. Rising Trend of Enzymes in Engineering
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diagnostic Specialty Enzymes, by Type, Application, Source, Reaction Type and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Diagnostic Specialty Enzymes (Value)
      • 5.2.1. Global Diagnostic Specialty Enzymes by: Type (Value)
        • 5.2.1.1. Protease
        • 5.2.1.2. Carbohydrase
        • 5.2.1.3. Lipase
        • 5.2.1.4. Polymerase and Nuclease
        • 5.2.1.5. Others
      • 5.2.2. Global Diagnostic Specialty Enzymes by: Application (Value)
        • 5.2.2.1. Food and Beverages
        • 5.2.2.2. Household Care
        • 5.2.2.3. Bioenergy
        • 5.2.2.4. Pharmaceutical and Biotechnology
        • 5.2.2.5. Feed
        • 5.2.2.6. Others
      • 5.2.3. Global Diagnostic Specialty Enzymes by: Source (Value)
        • 5.2.3.1. Microorganisms
        • 5.2.3.2. Plants
        • 5.2.3.3. Animals
      • 5.2.4. Global Diagnostic Specialty Enzymes by: Reaction Type (Value)
        • 5.2.4.1. Hydrolase
        • 5.2.4.2. Oxidoreductase
        • 5.2.4.3. Transferase
        • 5.2.4.4. Lyase
        • 5.2.4.5. Others
      • 5.2.5. Global Diagnostic Specialty Enzymes Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Diagnostic Specialty Enzymes (Price)
      • 5.3.1. Global Diagnostic Specialty Enzymes by: Type (Price)
  • 6. Diagnostic Specialty Enzymes: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BASF (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novozymes (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche Holding (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DuPont (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Roche Holding AG (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Codexis Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dyadic International (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Amano Enzymes (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Biocatalysts (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Life Technologies (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Advance Enzyme Technologies Ltd (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Affymetrix, Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Enzyme Supplies (United Kingdom)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. BBI Solutions (United Kingdom)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Specialty Enzymes & Probiotics (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Amicogen (South Korea)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Antozyme Biotech (India)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
      • 6.4.19. Enzyme Development Corporation (United States)
        • 6.4.19.1. Business Overview
        • 6.4.19.2. Products/Services Offerings
        • 6.4.19.3. Financial Analysis
        • 6.4.19.4. SWOT Analysis
  • 7. Global Diagnostic Specialty Enzymes Sale, by Type, Application, Source, Reaction Type and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Diagnostic Specialty Enzymes (Value)
      • 7.2.1. Global Diagnostic Specialty Enzymes by: Type (Value)
        • 7.2.1.1. Protease
        • 7.2.1.2. Carbohydrase
        • 7.2.1.3. Lipase
        • 7.2.1.4. Polymerase and Nuclease
        • 7.2.1.5. Others
      • 7.2.2. Global Diagnostic Specialty Enzymes by: Application (Value)
        • 7.2.2.1. Food and Beverages
        • 7.2.2.2. Household Care
        • 7.2.2.3. Bioenergy
        • 7.2.2.4. Pharmaceutical and Biotechnology
        • 7.2.2.5. Feed
        • 7.2.2.6. Others
      • 7.2.3. Global Diagnostic Specialty Enzymes by: Source (Value)
        • 7.2.3.1. Microorganisms
        • 7.2.3.2. Plants
        • 7.2.3.3. Animals
      • 7.2.4. Global Diagnostic Specialty Enzymes by: Reaction Type (Value)
        • 7.2.4.1. Hydrolase
        • 7.2.4.2. Oxidoreductase
        • 7.2.4.3. Transferase
        • 7.2.4.4. Lyase
        • 7.2.4.5. Others
      • 7.2.5. Global Diagnostic Specialty Enzymes Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Diagnostic Specialty Enzymes (Price)
      • 7.3.1. Global Diagnostic Specialty Enzymes by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diagnostic Specialty Enzymes: by Type(USD Million)
  • Table 2. Diagnostic Specialty Enzymes Protease , by Region USD Million (2017-2022)
  • Table 3. Diagnostic Specialty Enzymes Carbohydrase , by Region USD Million (2017-2022)
  • Table 4. Diagnostic Specialty Enzymes Lipase , by Region USD Million (2017-2022)
  • Table 5. Diagnostic Specialty Enzymes Polymerase and Nuclease , by Region USD Million (2017-2022)
  • Table 6. Diagnostic Specialty Enzymes Others , by Region USD Million (2017-2022)
  • Table 7. Diagnostic Specialty Enzymes: by Application(USD Million)
  • Table 8. Diagnostic Specialty Enzymes Food and Beverages , by Region USD Million (2017-2022)
  • Table 9. Diagnostic Specialty Enzymes Household Care , by Region USD Million (2017-2022)
  • Table 10. Diagnostic Specialty Enzymes Bioenergy , by Region USD Million (2017-2022)
  • Table 11. Diagnostic Specialty Enzymes Pharmaceutical and Biotechnology , by Region USD Million (2017-2022)
  • Table 12. Diagnostic Specialty Enzymes Feed , by Region USD Million (2017-2022)
  • Table 13. Diagnostic Specialty Enzymes Others , by Region USD Million (2017-2022)
  • Table 14. Diagnostic Specialty Enzymes: by Source(USD Million)
  • Table 15. Diagnostic Specialty Enzymes Microorganisms , by Region USD Million (2017-2022)
  • Table 16. Diagnostic Specialty Enzymes Plants , by Region USD Million (2017-2022)
  • Table 17. Diagnostic Specialty Enzymes Animals , by Region USD Million (2017-2022)
  • Table 18. Diagnostic Specialty Enzymes: by Reaction Type(USD Million)
  • Table 19. Diagnostic Specialty Enzymes Hydrolase , by Region USD Million (2017-2022)
  • Table 20. Diagnostic Specialty Enzymes Oxidoreductase , by Region USD Million (2017-2022)
  • Table 21. Diagnostic Specialty Enzymes Transferase , by Region USD Million (2017-2022)
  • Table 22. Diagnostic Specialty Enzymes Lyase , by Region USD Million (2017-2022)
  • Table 23. Diagnostic Specialty Enzymes Others , by Region USD Million (2017-2022)
  • Table 24. South America Diagnostic Specialty Enzymes, by Country USD Million (2017-2022)
  • Table 25. South America Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 26. South America Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 27. South America Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 28. South America Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 29. Brazil Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 30. Brazil Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 31. Brazil Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 32. Brazil Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 33. Argentina Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 34. Argentina Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 35. Argentina Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 36. Argentina Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 37. Rest of South America Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 38. Rest of South America Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 39. Rest of South America Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 40. Rest of South America Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 41. Asia Pacific Diagnostic Specialty Enzymes, by Country USD Million (2017-2022)
  • Table 42. Asia Pacific Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 43. Asia Pacific Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 44. Asia Pacific Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 45. Asia Pacific Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 46. China Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 47. China Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 48. China Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 49. China Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 50. Japan Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 51. Japan Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 52. Japan Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 53. Japan Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 54. India Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 55. India Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 56. India Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 57. India Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 58. South Korea Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 59. South Korea Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 60. South Korea Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 61. South Korea Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 62. Taiwan Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 63. Taiwan Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 64. Taiwan Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 65. Taiwan Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 66. Australia Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 67. Australia Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 68. Australia Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 69. Australia Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 74. Europe Diagnostic Specialty Enzymes, by Country USD Million (2017-2022)
  • Table 75. Europe Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 76. Europe Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 77. Europe Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 78. Europe Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 79. Germany Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 80. Germany Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 81. Germany Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 82. Germany Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 83. France Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 84. France Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 85. France Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 86. France Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 87. Italy Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 88. Italy Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 89. Italy Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 90. Italy Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 91. United Kingdom Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 92. United Kingdom Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 93. United Kingdom Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 94. United Kingdom Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 95. Netherlands Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 96. Netherlands Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 97. Netherlands Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 98. Netherlands Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 99. Rest of Europe Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 100. Rest of Europe Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 101. Rest of Europe Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 102. Rest of Europe Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 103. MEA Diagnostic Specialty Enzymes, by Country USD Million (2017-2022)
  • Table 104. MEA Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 105. MEA Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 106. MEA Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 107. MEA Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 108. Middle East Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 109. Middle East Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 110. Middle East Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 111. Middle East Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 112. Africa Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 113. Africa Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 114. Africa Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 115. Africa Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 116. North America Diagnostic Specialty Enzymes, by Country USD Million (2017-2022)
  • Table 117. North America Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 118. North America Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 119. North America Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 120. North America Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 121. United States Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 122. United States Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 123. United States Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 124. United States Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 125. Canada Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 126. Canada Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 127. Canada Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 128. Canada Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 129. Mexico Diagnostic Specialty Enzymes, by Type USD Million (2017-2022)
  • Table 130. Mexico Diagnostic Specialty Enzymes, by Application USD Million (2017-2022)
  • Table 131. Mexico Diagnostic Specialty Enzymes, by Source USD Million (2017-2022)
  • Table 132. Mexico Diagnostic Specialty Enzymes, by Reaction Type USD Million (2017-2022)
  • Table 133. Diagnostic Specialty Enzymes: by Type(USD/Units)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Diagnostic Specialty Enzymes: by Type(USD Million)
  • Table 154. Diagnostic Specialty Enzymes Protease , by Region USD Million (2023-2028)
  • Table 155. Diagnostic Specialty Enzymes Carbohydrase , by Region USD Million (2023-2028)
  • Table 156. Diagnostic Specialty Enzymes Lipase , by Region USD Million (2023-2028)
  • Table 157. Diagnostic Specialty Enzymes Polymerase and Nuclease , by Region USD Million (2023-2028)
  • Table 158. Diagnostic Specialty Enzymes Others , by Region USD Million (2023-2028)
  • Table 159. Diagnostic Specialty Enzymes: by Application(USD Million)
  • Table 160. Diagnostic Specialty Enzymes Food and Beverages , by Region USD Million (2023-2028)
  • Table 161. Diagnostic Specialty Enzymes Household Care , by Region USD Million (2023-2028)
  • Table 162. Diagnostic Specialty Enzymes Bioenergy , by Region USD Million (2023-2028)
  • Table 163. Diagnostic Specialty Enzymes Pharmaceutical and Biotechnology , by Region USD Million (2023-2028)
  • Table 164. Diagnostic Specialty Enzymes Feed , by Region USD Million (2023-2028)
  • Table 165. Diagnostic Specialty Enzymes Others , by Region USD Million (2023-2028)
  • Table 166. Diagnostic Specialty Enzymes: by Source(USD Million)
  • Table 167. Diagnostic Specialty Enzymes Microorganisms , by Region USD Million (2023-2028)
  • Table 168. Diagnostic Specialty Enzymes Plants , by Region USD Million (2023-2028)
  • Table 169. Diagnostic Specialty Enzymes Animals , by Region USD Million (2023-2028)
  • Table 170. Diagnostic Specialty Enzymes: by Reaction Type(USD Million)
  • Table 171. Diagnostic Specialty Enzymes Hydrolase , by Region USD Million (2023-2028)
  • Table 172. Diagnostic Specialty Enzymes Oxidoreductase , by Region USD Million (2023-2028)
  • Table 173. Diagnostic Specialty Enzymes Transferase , by Region USD Million (2023-2028)
  • Table 174. Diagnostic Specialty Enzymes Lyase , by Region USD Million (2023-2028)
  • Table 175. Diagnostic Specialty Enzymes Others , by Region USD Million (2023-2028)
  • Table 176. South America Diagnostic Specialty Enzymes, by Country USD Million (2023-2028)
  • Table 177. South America Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 178. South America Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 179. South America Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 180. South America Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 181. Brazil Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 182. Brazil Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 183. Brazil Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 184. Brazil Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 185. Argentina Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 186. Argentina Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 187. Argentina Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 188. Argentina Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 189. Rest of South America Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 190. Rest of South America Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 191. Rest of South America Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 192. Rest of South America Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 193. Asia Pacific Diagnostic Specialty Enzymes, by Country USD Million (2023-2028)
  • Table 194. Asia Pacific Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 195. Asia Pacific Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 196. Asia Pacific Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 197. Asia Pacific Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 198. China Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 199. China Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 200. China Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 201. China Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 202. Japan Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 203. Japan Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 204. Japan Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 205. Japan Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 206. India Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 207. India Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 208. India Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 209. India Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 210. South Korea Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 211. South Korea Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 212. South Korea Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 213. South Korea Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 214. Taiwan Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 215. Taiwan Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 216. Taiwan Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 217. Taiwan Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 218. Australia Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 219. Australia Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 220. Australia Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 221. Australia Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 222. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 223. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 224. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 225. Rest of Asia-Pacific Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 226. Europe Diagnostic Specialty Enzymes, by Country USD Million (2023-2028)
  • Table 227. Europe Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 228. Europe Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 229. Europe Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 230. Europe Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 231. Germany Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 232. Germany Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 233. Germany Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 234. Germany Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 235. France Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 236. France Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 237. France Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 238. France Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 239. Italy Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 240. Italy Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 241. Italy Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 242. Italy Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 243. United Kingdom Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 244. United Kingdom Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 245. United Kingdom Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 246. United Kingdom Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 247. Netherlands Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 248. Netherlands Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 249. Netherlands Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 250. Netherlands Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 251. Rest of Europe Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 252. Rest of Europe Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 253. Rest of Europe Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 254. Rest of Europe Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 255. MEA Diagnostic Specialty Enzymes, by Country USD Million (2023-2028)
  • Table 256. MEA Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 257. MEA Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 258. MEA Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 259. MEA Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 260. Middle East Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 261. Middle East Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 262. Middle East Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 263. Middle East Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 264. Africa Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 265. Africa Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 266. Africa Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 267. Africa Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 268. North America Diagnostic Specialty Enzymes, by Country USD Million (2023-2028)
  • Table 269. North America Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 270. North America Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 271. North America Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 272. North America Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 273. United States Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 274. United States Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 275. United States Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 276. United States Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 277. Canada Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 278. Canada Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 279. Canada Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 280. Canada Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 281. Mexico Diagnostic Specialty Enzymes, by Type USD Million (2023-2028)
  • Table 282. Mexico Diagnostic Specialty Enzymes, by Application USD Million (2023-2028)
  • Table 283. Mexico Diagnostic Specialty Enzymes, by Source USD Million (2023-2028)
  • Table 284. Mexico Diagnostic Specialty Enzymes, by Reaction Type USD Million (2023-2028)
  • Table 285. Diagnostic Specialty Enzymes: by Type(USD/Units)
  • Table 286. Research Programs/Design for This Report
  • Table 287. Key Data Information from Secondary Sources
  • Table 288. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diagnostic Specialty Enzymes: by Type USD Million (2017-2022)
  • Figure 5. Global Diagnostic Specialty Enzymes: by Application USD Million (2017-2022)
  • Figure 6. Global Diagnostic Specialty Enzymes: by Source USD Million (2017-2022)
  • Figure 7. Global Diagnostic Specialty Enzymes: by Reaction Type USD Million (2017-2022)
  • Figure 8. South America Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 9. Asia Pacific Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 10. Europe Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 11. MEA Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 12. North America Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 13. Global Diagnostic Specialty Enzymes: by Type USD/Units (2017-2022)
  • Figure 14. Global Diagnostic Specialty Enzymes share by Players 2022 (%)
  • Figure 15. Global Diagnostic Specialty Enzymes share by Players (Top 3) 2022(%)
  • Figure 16. Global Diagnostic Specialty Enzymes share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. BASF (Germany) Revenue, Net Income and Gross profit
  • Figure 19. BASF (Germany) Revenue: by Geography 2022
  • Figure 20. Novozymes (Denmark) Revenue, Net Income and Gross profit
  • Figure 21. Novozymes (Denmark) Revenue: by Geography 2022
  • Figure 22. Roche Holding (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Roche Holding (Switzerland) Revenue: by Geography 2022
  • Figure 24. DuPont (United States) Revenue, Net Income and Gross profit
  • Figure 25. DuPont (United States) Revenue: by Geography 2022
  • Figure 26. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Roche Holding AG (Switzerland) Revenue: by Geography 2022
  • Figure 28. Codexis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Codexis Inc. (United States) Revenue: by Geography 2022
  • Figure 30. Dyadic International (United States) Revenue, Net Income and Gross profit
  • Figure 31. Dyadic International (United States) Revenue: by Geography 2022
  • Figure 32. Amano Enzymes (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Amano Enzymes (Japan) Revenue: by Geography 2022
  • Figure 34. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 35. Sanofi (France) Revenue: by Geography 2022
  • Figure 36. Biocatalysts (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. Biocatalysts (United Kingdom) Revenue: by Geography 2022
  • Figure 38. Life Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 39. Life Technologies (United States) Revenue: by Geography 2022
  • Figure 40. Advance Enzyme Technologies Ltd (India) Revenue, Net Income and Gross profit
  • Figure 41. Advance Enzyme Technologies Ltd (India) Revenue: by Geography 2022
  • Figure 42. Affymetrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 43. Affymetrix, Inc. (United States) Revenue: by Geography 2022
  • Figure 44. Enzyme Supplies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 45. Enzyme Supplies (United Kingdom) Revenue: by Geography 2022
  • Figure 46. BBI Solutions (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 47. BBI Solutions (United Kingdom) Revenue: by Geography 2022
  • Figure 48. Specialty Enzymes & Probiotics (United States) Revenue, Net Income and Gross profit
  • Figure 49. Specialty Enzymes & Probiotics (United States) Revenue: by Geography 2022
  • Figure 50. Amicogen (South Korea) Revenue, Net Income and Gross profit
  • Figure 51. Amicogen (South Korea) Revenue: by Geography 2022
  • Figure 52. Antozyme Biotech (India) Revenue, Net Income and Gross profit
  • Figure 53. Antozyme Biotech (India) Revenue: by Geography 2022
  • Figure 54. Enzyme Development Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 55. Enzyme Development Corporation (United States) Revenue: by Geography 2022
  • Figure 56. Global Diagnostic Specialty Enzymes: by Type USD Million (2023-2028)
  • Figure 57. Global Diagnostic Specialty Enzymes: by Application USD Million (2023-2028)
  • Figure 58. Global Diagnostic Specialty Enzymes: by Source USD Million (2023-2028)
  • Figure 59. Global Diagnostic Specialty Enzymes: by Reaction Type USD Million (2023-2028)
  • Figure 60. South America Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 61. Asia Pacific Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 62. Europe Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 63. MEA Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 64. North America Diagnostic Specialty Enzymes Share (%), by Country
  • Figure 65. Global Diagnostic Specialty Enzymes: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • BASF (Germany)
  • Novozymes (Denmark)
  • Roche Holding (Switzerland)
  • DuPont (United States)
  • Roche Holding AG (Switzerland)
  • Codexis Inc. (United States)
  • Dyadic International (United States)
  • Amano Enzymes (Japan)
  • Sanofi (France)
  • Biocatalysts (United Kingdom)
  • Life Technologies (United States)
  • Advance Enzyme Technologies Ltd (India)
  • Affymetrix, Inc. (United States)
  • Enzyme Supplies (United Kingdom)
  • BBI Solutions (United Kingdom)
  • Specialty Enzymes & Probiotics (United States)
  • Amicogen (South Korea)
  • Antozyme Biotech (India)
  • Enzyme Development Corporation (United States)
Additional players considered in the study are as follows:
Nagase & Co. Ltd. (Japan) , Sekisui Diagnostics (United States) , Merck (Germany) , Biovet (Bulgaria) , Biotec Pharmacon
Select User Access Type

Key Highlights of Report


Dec 2023 143 Pages 53 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Diagnostic Specialty Enzymes Market Quantitative research analysis
Global Diagnostic Specialty Enzymes Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Diagnostic Specialty Enzymes Market are by type [Protease, Carbohydrase, Lipase, Polymerase and Nuclease and Others], by end use application [Food and Beverages, Household Care, Bioenergy, Pharmaceutical and Biotechnology, Feed and Others].
The Diagnostic Specialty Enzymes Market is gaining popularity and expected to see strong valuation by 2028.
  • Rising Number for Patient Suffering From Chronic Diseases
  • Rising in Prevalence of Digestive Disorders
  • Increasing Demand for Biofuels
  • Rising Demand for Effective Diagnostic Specialty Enzymes Based Pharmaceuticals

Know More About Global Diagnostic Specialty Enzymes Market Report?

Have a Query? Click Here

Other Related Reports

Swab and Viral Transport Medium Comprehensive Study by Type (Nasopharyngeal, Oropharyngeal, Others), Application (Diagnosis of Viral Infections, Preclinical Testing, Others), End-User (Microbiology L...
$ 3650
Doxycycline Comprehensive Study by Type (Capsules, Tablets, Syrup, Oral Suspension, Injection Powder, Periodontal Extended Release Liquid), Application (Ureaplasma, Typhus, Chancroid, Brucellosis, An...
$ 3650
Disposable Medical Pulp Products Comprehensive Study by Type (Detergent Proof Wash Bowl, General Purpose Bowl, Kidney Dish, Commode Pan Liner, CS Receiver, Urinals), Application (Surgeries, Hospitals...
$ 3600
Dental Desensitizer Comprehensive Study by Type (Fluoride-containing Dental Desensitizer, Fluoride-free Dental Desensitizer), Application (Hospitals, Clinics, Pharmacy, Others), Distribution Channel ...
$ 3650
Ambulatory Surgery Comprehensive Study by Application (Ophthalmology, Orthopedics, Gastroenterology, Pain management/spinal injection, Plastic surgery, Others), Specialty (Single-Specialty, Multi-Spe...
$ 3800
Home Care Services Comprehensive Study by Type (Traditional Home Health & Nursing care, Home Hospice, Home Therapy Services, Homemaker & Personal Services, Others), Age Group (15-24 Years, 25-34 Year...
$ 3450